In light of medicare advancements and the rising prevalence of life-threatening diseases, healthcare professionals are gradually making a shift toward injectable drug delivery systems from the hitherto oral medication solutions. The injectable drug delivery market is, according to industry analysis, estimated to be around a staggering US$ 49.44 billion, as of 2024. With the integration of telemedicine services, in the developing and developed parts of the world, this market is further slated to follow an upward surge.
Pharmaceutical companies in this industry are also leveraging this opportunity by curating more efficient devices, such as injectable, prefilled syringes, auto-injectors, and pen-injectors, for treating chronic and age-related conditions such as diabetes, hypertension, and arthritis. This has fueled the market to grow at a healthy CAGR of 8.70% through 2034.
The largest consumer group the companies are targeting in this market are the patients diagnosed with diabetes. In the United States alone, over 11.6% of the total population has diabetes at some level. This has set the right precedent for companies involved in this industry to market their offerings in the country. With the prevalence of diabetes and chronic diseases growing globally, the valuation is prone to hit US$ 113.87 billion by the end of 2034.
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 49.44 billion |
| Projected Market Value for 2034 | US$ 113.87 billion |
| Value-based CAGR of the Market (2024 to 2034) | 8.70% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Many devices come under the purview of injectable drug delivery solutions such as self-injectors, needle-free injectors, auto-injectors, wearable injectors, and insulin pins. The insulin pins segment is expected to hold the predominant market share of 50.50% as of 2024.
| Attributes | Details |
|---|---|
| Product Type | Insulin Pins |
| Market Share (2024) | 50.50% |
On the basis of technology, injectable drug delivery systems are bifurcated into non-smart injectors and smart injectors. The former is slated to hold a market share of 83.80% as of 2024.
| Attributes | Details |
|---|---|
| Technology | Non-smart injectors |
| Market Share (2024) | 83.80% |
The biggest factor why medical professionals, even patients using injectable drug delivery systems, prefer non-smart injectors is due to their affordability. This makes them accessible to a wider range of consumers, especially those living in underdeveloped parts of the world.
Familiarity is another reason why lots of medical professionals choose non-smart injectors over smart ones. Apart from this, these injectors are simple to use and typically have straightforward mechanisms that require less training.
Principal Consultant
| Countries | CAGR (2024 to 2034) |
|---|---|
| China | 10.10% |
| Brazil | 9.80% |
| India | 9.50% |
| United Kingdom | 8.80% |
| Japan | 8.50% |
The market in China is a promising one. It is slated to progress at a CAGR of 10.10% through 2034.
The Chinese government since the pandemic has invested billions of dollars in making their healthcare system more advanced, sophisticated, and mechanized. This has led to a multitude of collaborations within the industry which is not only enhancing healthcare infrastructure but also increasing the adoption of modern equipment such as automatic injectors, needle-less drug delivers, etc.
For instance, in July 2021, Aptar announced the acquisition of 80% equity in Weihai Hengyu Medical Products Co., Ltd., bolstering its presence in China's market. This move aimed to enhance local manufacturing capacity and better serve regional and global customers.
Brazil is a lucrative country for the market. The market is anticipated to surge at a CAGR of 9.80% in the country.
According to a recent survey by NCBI, sexually transmitted diseases in Brazil have taken a tremendous jump by growing at a rate of 21% from 2010. This has forced drug delivery companies to curate injectable drugs and devices to combat this escalating health crisis.
A multitude of companies have already applied for approvals from the regulatory bodies in Brazil. For example, in June 2023, Brazil’s federal health regulator Anvisa approved injectable cabotegravir, a pre-exposure prophylaxis (PrEP) medication for HIV AIDS.
The India injectable drug delivery market is likely to flourish in the coming years. It is slated to inflate at a CAGR of 9.50% through 2034.
Since the pandemic, the Indian drug delivery market has seen a tremendous upward trend. Government as well as private healthcare companies are pouring billions of dollars into curating efficient devices and methodologies for drug deliveries to battle the nation's rising prevalence of chronic diseases.
The industry-academia collaboration has also benefited the market. For instance, in September 2019, Indian Institute of Technology Guwahati (IIT Guwahati) researchers developed nanomaterials from nature for controlled drug delivery, potentially targeting chemotherapy drugs directly to cancer cells, bypassing healthy cells.
The future of the United Kingdom injectable drug delivery market looks bright. The market is slated to rise at a CAGR of 8.80% through 2034 in the country.
The United Kingdom is currently dealing with the problem of rising obesity rates among its general population. The Health Survey for England 2021 estimates that 25.9% of adults in England are obese, which has forced medicare companies to curate weight-loss injectables. For instance, the United Kingdom’s Medicines and Healthcare Products Regulatory Agency recently approved Eli Lilly’s injectable diabetes medication for use as a weight loss treatment.
The market in Japan is slated to develop at a CAGR of 8.50% for the forecasted period of 2024 to 2034.
Japan is currently dealing with the problem of a growing aging population. This has pushed companies in the market to curate injectable drug delivery solutions that allow patients to take medications for chronic diseases, like hypertension, Alzheimer's, etc., at home.
For example, Japanese pharmaceutical company Eisai has planned to develop lecanemab, the Alzheimer's disease drug that has been approved in the USA for intravenous administration, so that it can be easily injected subcutaneously by patients or caregivers at home.
The market is an ever-evolving one with innovations and methodologies making constant entries into the market. With international companies investing billions of dollars in curating new devices and medical procedures for the healthcare sector, the market is very likely to experience an upward trend.
Domestic companies are developing devices according to the country’s needs. For example, Japanese companies are developing products for problems related to the aging population, the United Kingdom for obesity, and India for chronic diseases.
Recent Developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is expected to be worth US$ US$ 49.44 billion in 2024.
The injectable drug delivery market is expected to reach US$ 113.87 billion by 2034.
The market is in line to develop at a CAGR of 8.70% from 2024 to 2034.
Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, and Medtronic plc, are some of the major players in the global injectable drug delivery market.
The market valuation in 2023 was US$ 45.26 billion.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Manufacturer
3.5.1.2. Mid-Level Participants (Traders)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2024 to 2034
5.3.1. Self-Injector
5.3.2. Needle Free Injectors
5.3.3. Auto-Injectors
5.3.4. Wearable Injectors
5.3.5. Insulin Pens
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Technology, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Technology, 2024 to 2034
6.3.1. Non-Smart Injectors
6.3.2. Smart Injectors
6.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Usage
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Usage, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Usage, 2024 to 2034
7.3.1. Disposable Injectors
7.3.2. Reusable Injectors
7.4. Y-o-Y Growth Trend Analysis By Usage, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Usage, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2024 to 2034
8.3.1. Anaphylaxis
8.3.2. Diabetes
8.3.3. Cardiovascular Disease
8.3.4. Multiple Sclerosis
8.3.5. Rheumatoid Arthritis
8.3.6. Cancer
8.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023
9.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034
9.3.1. Hospital Pharmacies
9.3.2. Drug Stores
9.3.3. Retail Pharmacies
9.3.4. Online Pharmacies
9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
10.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Product Type
11.2.3. By Technology
11.2.4. By Usage
11.2.5. By Indication
11.2.6. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Technology
11.3.4. By Usage
11.3.5. By Indication
11.3.6. By Distribution Channel
11.4. Key Takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Product Type
12.2.3. By Technology
12.2.4. By Usage
12.2.5. By Indication
12.2.6. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Technology
12.3.4. By Usage
12.3.5. By Indication
12.3.6. By Distribution Channel
12.4. Key Takeaways
13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. UK
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Product Type
13.2.3. By Technology
13.2.4. By Usage
13.2.5. By Indication
13.2.6. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Technology
13.3.4. By Usage
13.3.5. By Indication
13.3.6. By Distribution Channel
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Product Type
14.2.3. By Technology
14.2.4. By Usage
14.2.5. By Indication
14.2.6. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Technology
14.3.4. By Usage
14.3.5. By Indication
14.3.6. By Distribution Channel
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Product Type
15.2.3. By Technology
15.2.4. By Usage
15.2.5. By Indication
15.2.6. By Distribution Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Technology
15.3.4. By Usage
15.3.5. By Indication
15.3.6. By Distribution Channel
15.4. Key Takeaways
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Product Type
16.2.3. By Technology
16.2.4. By Usage
16.2.5. By Indication
16.2.6. By Distribution Channel
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Technology
16.3.4. By Usage
16.3.5. By Indication
16.3.6. By Distribution Channel
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
17.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
17.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Product Type
17.2.3. By Technology
17.2.4. By Usage
17.2.5. By Indication
17.2.6. By Distribution Channel
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Product Type
17.3.3. By Technology
17.3.4. By Usage
17.3.5. By Indication
17.3.6. By Distribution Channel
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2023
18.1.2.1. By Product Type
18.1.2.2. By Technology
18.1.2.3. By Usage
18.1.2.4. By Indication
18.1.2.5. By Distribution Channel
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2023
18.2.2.1. By Product Type
18.2.2.2. By Technology
18.2.2.3. By Usage
18.2.2.4. By Indication
18.2.2.5. By Distribution Channel
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2023
18.3.2.1. By Product Type
18.3.2.2. By Technology
18.3.2.3. By Usage
18.3.2.4. By Indication
18.3.2.5. By Distribution Channel
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2023
18.4.2.1. By Product Type
18.4.2.2. By Technology
18.4.2.3. By Usage
18.4.2.4. By Indication
18.4.2.5. By Distribution Channel
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2023
18.5.2.1. By Product Type
18.5.2.2. By Technology
18.5.2.3. By Usage
18.5.2.4. By Indication
18.5.2.5. By Distribution Channel
18.6. UK
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2023
18.6.2.1. By Product Type
18.6.2.2. By Technology
18.6.2.3. By Usage
18.6.2.4. By Indication
18.6.2.5. By Distribution Channel
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2023
18.7.2.1. By Product Type
18.7.2.2. By Technology
18.7.2.3. By Usage
18.7.2.4. By Indication
18.7.2.5. By Distribution Channel
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2023
18.8.2.1. By Product Type
18.8.2.2. By Technology
18.8.2.3. By Usage
18.8.2.4. By Indication
18.8.2.5. By Distribution Channel
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2023
18.9.2.1. By Product Type
18.9.2.2. By Technology
18.9.2.3. By Usage
18.9.2.4. By Indication
18.9.2.5. By Distribution Channel
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2023
18.10.2.1. By Product Type
18.10.2.2. By Technology
18.10.2.3. By Usage
18.10.2.4. By Indication
18.10.2.5. By Distribution Channel
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2023
18.11.2.1. By Product Type
18.11.2.2. By Technology
18.11.2.3. By Usage
18.11.2.4. By Indication
18.11.2.5. By Distribution Channel
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2023
18.12.2.1. By Product Type
18.12.2.2. By Technology
18.12.2.3. By Usage
18.12.2.4. By Indication
18.12.2.5. By Distribution Channel
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2023
18.13.2.1. By Product Type
18.13.2.2. By Technology
18.13.2.3. By Usage
18.13.2.4. By Indication
18.13.2.5. By Distribution Channel
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2023
18.14.2.1. By Product Type
18.14.2.2. By Technology
18.14.2.3. By Usage
18.14.2.4. By Indication
18.14.2.5. By Distribution Channel
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2023
18.15.2.1. By Product Type
18.15.2.2. By Technology
18.15.2.3. By Usage
18.15.2.4. By Indication
18.15.2.5. By Distribution Channel
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2023
18.16.2.1. By Product Type
18.16.2.2. By Technology
18.16.2.3. By Usage
18.16.2.4. By Indication
18.16.2.5. By Distribution Channel
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2023
18.17.2.1. By Product Type
18.17.2.2. By Technology
18.17.2.3. By Usage
18.17.2.4. By Indication
18.17.2.5. By Distribution Channel
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2023
18.18.2.1. By Product Type
18.18.2.2. By Technology
18.18.2.3. By Usage
18.18.2.4. By Indication
18.18.2.5. By Distribution Channel
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2023
18.19.2.1. By Product Type
18.19.2.2. By Technology
18.19.2.3. By Usage
18.19.2.4. By Indication
18.19.2.5. By Distribution Channel
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2023
18.20.2.1. By Product Type
18.20.2.2. By Technology
18.20.2.3. By Usage
18.20.2.4. By Indication
18.20.2.5. By Distribution Channel
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2023
18.21.2.1. By Product Type
18.21.2.2. By Technology
18.21.2.3. By Usage
18.21.2.4. By Indication
18.21.2.5. By Distribution Channel
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2023
18.22.2.1. By Product Type
18.22.2.2. By Technology
18.22.2.3. By Usage
18.22.2.4. By Indication
18.22.2.5. By Distribution Channel
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2023
18.23.2.1. By Product Type
18.23.2.2. By Technology
18.23.2.3. By Usage
18.23.2.4. By Indication
18.23.2.5. By Distribution Channel
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Product Type
19.3.3. By Technology
19.3.4. By Usage
19.3.5. By Indication
19.3.6. By Distribution Channel
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. Amgen Inc.
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.1.5.2. Product Strategy
20.1.1.5.3. Channel Strategy
20.1.2. Antares Pharma Inc.
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.2.5.2. Product Strategy
20.1.2.5.3. Channel Strategy
20.1.3. Becton Dickinson and Company
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.3.5.2. Product Strategy
20.1.3.5.3. Channel Strategy
20.1.4. Consort Medical Plc
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.4.5.2. Product Strategy
20.1.4.5.3. Channel Strategy
20.1.5. Crossjet
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.5.5.2. Product Strategy
20.1.5.5.3. Channel Strategy
20.1.6. Medtronic plc,
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.6.5.2. Product Strategy
20.1.6.5.3. Channel Strategy
20.1.7. Mylan N.V.
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.7.5.2. Product Strategy
20.1.7.5.3. Channel Strategy
20.1.8. SHL Group
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.8.5.2. Product Strategy
20.1.8.5.3. Channel Strategy
20.1.9. West Pharmaceutical Services
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.9.5.2. Product Strategy
20.1.9.5.3. Channel Strategy
20.1.10. Ypsomed
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.10.5.2. Product Strategy
20.1.10.5.3. Channel Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Injectable Drug Delivery Market
